Table of Content

1 Histone Deacetylase (HDAC) Inhibitors Market Overview
1.1 Product Overview and Scope of Histone Deacetylase (HDAC) Inhibitors
1.2 Histone Deacetylase (HDAC) Inhibitors Segment by Type
1.2.1 Global Histone Deacetylase (HDAC) Inhibitors Market Value Comparison by Type (2024-2034)
1.2.2 Fatty Acid
1.2.3 Hydroxamate
1.2.4 Cyclic Peptide
1.2.5 Benzamide
1.3 Histone Deacetylase (HDAC) Inhibitors Segment by Application
1.3.1 Global Histone Deacetylase (HDAC) Inhibitors Market Value by Application: (2024-2034)
1.3.2 Treatment of Malignant Tumors
1.3.3 Chronic Disease Treatment
1.3.4 Others
1.4 Global Histone Deacetylase (HDAC) Inhibitors Market Size Estimates and Forecasts
1.4.1 Global Histone Deacetylase (HDAC) Inhibitors Revenue 2018-2029
1.4.2 Global Histone Deacetylase (HDAC) Inhibitors Sales 2018-2029
1.4.3 Global Histone Deacetylase (HDAC) Inhibitors Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Histone Deacetylase (HDAC) Inhibitors Market Competition by Manufacturers
2.1 Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Manufacturers (2018-2024)
2.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Histone Deacetylase (HDAC) Inhibitors Average Price by Manufacturers (2018-2024)
2.4 Global Histone Deacetylase (HDAC) Inhibitors Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Histone Deacetylase (HDAC) Inhibitors, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Histone Deacetylase (HDAC) Inhibitors, Product Type & Application
2.7 Histone Deacetylase (HDAC) Inhibitors Market Competitive Situation and Trends
2.7.1 Histone Deacetylase (HDAC) Inhibitors Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Histone Deacetylase (HDAC) Inhibitors Players Market Share by Revenue
2.7.3 Global Histone Deacetylase (HDAC) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Histone Deacetylase (HDAC) Inhibitors Retrospective Market Scenario by Region
3.1 Global Histone Deacetylase (HDAC) Inhibitors Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Histone Deacetylase (HDAC) Inhibitors Global Histone Deacetylase (HDAC) Inhibitors Sales by Region: 2018-2029
3.2.1 Global Histone Deacetylase (HDAC) Inhibitors Sales by Region: 2018-2024
3.2.2 Global Histone Deacetylase (HDAC) Inhibitors Sales by Region: 2024-2029
3.3 Global Histone Deacetylase (HDAC) Inhibitors Global Histone Deacetylase (HDAC) Inhibitors Revenue by Region: 2018-2029
3.3.1 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Region: 2018-2024
3.3.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Region: 2024-2029
3.4 North America Histone Deacetylase (HDAC) Inhibitors Market Facts & Figures by Country
3.4.1 North America Histone Deacetylase (HDAC) Inhibitors Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2018-2029)
3.4.3 North America Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Histone Deacetylase (HDAC) Inhibitors Market Facts & Figures by Country
3.5.1 Europe Histone Deacetylase (HDAC) Inhibitors Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Histone Deacetylase (HDAC) Inhibitors Sales by Country (2018-2029)
3.5.3 Europe Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Histone Deacetylase (HDAC) Inhibitors Market Facts & Figures by Country
3.6.1 Asia Pacific Histone Deacetylase (HDAC) Inhibitors Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Histone Deacetylase (HDAC) Inhibitors Sales by Country (2018-2029)
3.6.3 Asia Pacific Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Histone Deacetylase (HDAC) Inhibitors Market Facts & Figures by Country
3.7.1 Latin America Histone Deacetylase (HDAC) Inhibitors Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2018-2029)
3.7.3 Latin America Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Market Facts & Figures by Country
3.8.1 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales by Country (2018-2029)
3.8.3 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Histone Deacetylase (HDAC) Inhibitors Sales by Type (2018-2029)
4.1.1 Global Histone Deacetylase (HDAC) Inhibitors Sales by Type (2018-2024)
4.1.2 Global Histone Deacetylase (HDAC) Inhibitors Sales by Type (2024-2029)
4.1.3 Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Type (2018-2029)
4.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Type (2018-2029)
4.2.1 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Type (2018-2024)
4.2.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Type (2024-2029)
4.2.3 Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Type (2018-2029)
4.3 Global Histone Deacetylase (HDAC) Inhibitors Price by Type (2018-2029)
5 Segment by Application
5.1 Global Histone Deacetylase (HDAC) Inhibitors Sales by Application (2018-2029)
5.1.1 Global Histone Deacetylase (HDAC) Inhibitors Sales by Application (2018-2024)
5.1.2 Global Histone Deacetylase (HDAC) Inhibitors Sales by Application (2024-2029)
5.1.3 Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Application (2018-2029)
5.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Application (2018-2029)
5.2.1 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Application (2018-2024)
5.2.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Application (2024-2029)
5.2.3 Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Application (2018-2029)
5.3 Global Histone Deacetylase (HDAC) Inhibitors Price by Application (2018-2029)
6 Key Companies Profiled
6.1 4SC
6.1.1 4SC Corporation Information
6.1.2 4SC Description and Business Overview
6.1.3 4SC Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
6.1.4 4SC Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.1.5 4SC Recent Developments/Updates
6.2 Acetylon Pharmaceuticals
6.2.1 Acetylon Pharmaceuticals Corporation Information
6.2.2 Acetylon Pharmaceuticals Description and Business Overview
6.2.3 Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.2.5 Acetylon Pharmaceuticals Recent Developments/Updates
6.3 Celleron Therapeutics
6.3.1 Celleron Therapeutics Corporation Information
6.3.2 Celleron Therapeutics Description and Business Overview
6.3.3 Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.3.5 Celleron Therapeutics Recent Developments/Updates
6.4 Chipscreen Biosciences
6.4.1 Chipscreen Biosciences Corporation Information
6.4.2 Chipscreen Biosciences Description and Business Overview
6.4.3 Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.4.5 Chipscreen Biosciences Recent Developments/Updates
6.5 Chroma Therapeutics
6.5.1 Chroma Therapeutics Corporation Information
6.5.2 Chroma Therapeutics Description and Business Overview
6.5.3 Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.5.5 Chroma Therapeutics Recent Developments/Updates
6.6 CrystalGenomics
6.6.1 CrystalGenomics Corporation Information
6.6.2 CrystalGenomics Description and Business Overview
6.6.3 CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
6.6.4 CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.6.5 CrystalGenomics Recent Developments/Updates
6.7 Curis
6.6.1 Curis Corporation Information
6.6.2 Curis Description and Business Overview
6.6.3 Curis Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Curis Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.7.5 Curis Recent Developments/Updates
6.8 MEI Pharma
6.8.1 MEI Pharma Corporation Information
6.8.2 MEI Pharma Description and Business Overview
6.8.3 MEI Pharma Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
6.8.4 MEI Pharma Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.8.5 MEI Pharma Recent Developments/Updates
6.9 Mirati Therapeutics
6.9.1 Mirati Therapeutics Corporation Information
6.9.2 Mirati Therapeutics Description and Business Overview
6.9.3 Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.9.5 Mirati Therapeutics Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Corporation Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Novartis Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 Onxeo
6.11.1 Onxeo Corporation Information
6.11.2 Onxeo Histone Deacetylase (HDAC) Inhibitors Description and Business Overview
6.11.3 Onxeo Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Onxeo Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.11.5 Onxeo Recent Developments/Updates
6.12 Repligen
6.12.1 Repligen Corporation Information
6.12.2 Repligen Histone Deacetylase (HDAC) Inhibitors Description and Business Overview
6.12.3 Repligen Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Repligen Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.12.5 Repligen Recent Developments/Updates
6.13 TetraLogic
6.13.1 TetraLogic Corporation Information
6.13.2 TetraLogic Histone Deacetylase (HDAC) Inhibitors Description and Business Overview
6.13.3 TetraLogic Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
6.13.4 TetraLogic Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.13.5 TetraLogic Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Histone Deacetylase (HDAC) Inhibitors Industry Chain Analysis
7.2 Histone Deacetylase (HDAC) Inhibitors Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Histone Deacetylase (HDAC) Inhibitors Production Mode & Process
7.4 Histone Deacetylase (HDAC) Inhibitors Sales and Marketing
7.4.1 Histone Deacetylase (HDAC) Inhibitors Sales Channels
7.4.2 Histone Deacetylase (HDAC) Inhibitors Distributors
7.5 Histone Deacetylase (HDAC) Inhibitors Customers
8 Histone Deacetylase (HDAC) Inhibitors Market Dynamics
8.1 Histone Deacetylase (HDAC) Inhibitors Industry Trends
8.2 Histone Deacetylase (HDAC) Inhibitors Market Drivers
8.3 Histone Deacetylase (HDAC) Inhibitors Market Challenges
8.4 Histone Deacetylase (HDAC) Inhibitors Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Histone Deacetylase (HDAC) Inhibitors Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Histone Deacetylase (HDAC) Inhibitors Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Histone Deacetylase (HDAC) Inhibitors Market Competitive Situation by Manufacturers in 2022
Table 4. Global Histone Deacetylase (HDAC) Inhibitors Sales (MT) of Key Manufacturers (2018-2024)
Table 5. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Histone Deacetylase (HDAC) Inhibitors Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Histone Deacetylase (HDAC) Inhibitors Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Histone Deacetylase (HDAC) Inhibitors Average Price (USD/MT) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Histone Deacetylase (HDAC) Inhibitors, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Histone Deacetylase (HDAC) Inhibitors, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Histone Deacetylase (HDAC) Inhibitors, Product Type & Application
Table 12. Global Key Manufacturers of Histone Deacetylase (HDAC) Inhibitors, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Histone Deacetylase (HDAC) Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Histone Deacetylase (HDAC) Inhibitors as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Histone Deacetylase (HDAC) Inhibitors Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Histone Deacetylase (HDAC) Inhibitors Sales by Region (2018-2024) & (MT)
Table 18. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Region (2018-2024)
Table 19. Global Histone Deacetylase (HDAC) Inhibitors Sales by Region (2024-2029) & (MT)
Table 20. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Region (2024-2029)
Table 21. Global Histone Deacetylase (HDAC) Inhibitors Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Region (2018-2024)
Table 23. Global Histone Deacetylase (HDAC) Inhibitors Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Region (2024-2029)
Table 25. North America Histone Deacetylase (HDAC) Inhibitors Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2018-2024) & (MT)
Table 27. North America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2024-2029) & (MT)
Table 28. North America Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Histone Deacetylase (HDAC) Inhibitors Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Histone Deacetylase (HDAC) Inhibitors Sales by Country (2018-2024) & (MT)
Table 32. Europe Histone Deacetylase (HDAC) Inhibitors Sales by Country (2024-2029) & (MT)
Table 33. Europe Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Histone Deacetylase (HDAC) Inhibitors Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Histone Deacetylase (HDAC) Inhibitors Sales by Region (2018-2024) & (MT)
Table 37. Asia Pacific Histone Deacetylase (HDAC) Inhibitors Sales by Region (2024-2029) & (MT)
Table 38. Asia Pacific Histone Deacetylase (HDAC) Inhibitors Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Histone Deacetylase (HDAC) Inhibitors Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Histone Deacetylase (HDAC) Inhibitors Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2018-2024) & (MT)
Table 42. Latin America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2024-2029) & (MT)
Table 43. Latin America Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Sales by Country (2018-2024) & (MT)
Table 47. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Sales by Country (2024-2029) & (MT)
Table 48. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Histone Deacetylase (HDAC) Inhibitors Sales (MT) by Type (2018-2024)
Table 51. Global Histone Deacetylase (HDAC) Inhibitors Sales (MT) by Type (2024-2029)
Table 52. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Type (2018-2024)
Table 53. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Type (2024-2029)
Table 54. Global Histone Deacetylase (HDAC) Inhibitors Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Histone Deacetylase (HDAC) Inhibitors Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Type (2018-2024)
Table 57. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Type (2024-2029)
Table 58. Global Histone Deacetylase (HDAC) Inhibitors Price (USD/MT) by Type (2018-2024)
Table 59. Global Histone Deacetylase (HDAC) Inhibitors Price (USD/MT) by Type (2024-2029)
Table 60. Global Histone Deacetylase (HDAC) Inhibitors Sales (MT) by Application (2018-2024)
Table 61. Global Histone Deacetylase (HDAC) Inhibitors Sales (MT) by Application (2024-2029)
Table 62. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Application (2018-2024)
Table 63. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Application (2024-2029)
Table 64. Global Histone Deacetylase (HDAC) Inhibitors Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Histone Deacetylase (HDAC) Inhibitors Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Application (2018-2024)
Table 67. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Application (2024-2029)
Table 68. Global Histone Deacetylase (HDAC) Inhibitors Price (USD/MT) by Application (2018-2024)
Table 69. Global Histone Deacetylase (HDAC) Inhibitors Price (USD/MT) by Application (2024-2029)
Table 70. 4SC Corporation Information
Table 71. 4SC Description and Business Overview
Table 72. 4SC Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 73. 4SC Histone Deacetylase (HDAC) Inhibitors Product
Table 74. 4SC Recent Developments/Updates
Table 75. Acetylon Pharmaceuticals Corporation Information
Table 76. Acetylon Pharmaceuticals Description and Business Overview
Table 77. Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 78. Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Product
Table 79. Acetylon Pharmaceuticals Recent Developments/Updates
Table 80. Celleron Therapeutics Corporation Information
Table 81. Celleron Therapeutics Description and Business Overview
Table 82. Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 83. Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Product
Table 84. Celleron Therapeutics Recent Developments/Updates
Table 85. Chipscreen Biosciences Corporation Information
Table 86. Chipscreen Biosciences Description and Business Overview
Table 87. Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 88. Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Product
Table 89. Chipscreen Biosciences Recent Developments/Updates
Table 90. Chroma Therapeutics Corporation Information
Table 91. Chroma Therapeutics Description and Business Overview
Table 92. Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 93. Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Product
Table 94. Chroma Therapeutics Recent Developments/Updates
Table 95. CrystalGenomics Corporation Information
Table 96. CrystalGenomics Description and Business Overview
Table 97. CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 98. CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Product
Table 99. CrystalGenomics Recent Developments/Updates
Table 100. Curis Corporation Information
Table 101. Curis Description and Business Overview
Table 102. Curis Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 103. Curis Histone Deacetylase (HDAC) Inhibitors Product
Table 104. Curis Recent Developments/Updates
Table 105. MEI Pharma Corporation Information
Table 106. MEI Pharma Description and Business Overview
Table 107. MEI Pharma Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 108. MEI Pharma Histone Deacetylase (HDAC) Inhibitors Product
Table 109. MEI Pharma Recent Developments/Updates
Table 110. Mirati Therapeutics Corporation Information
Table 111. Mirati Therapeutics Description and Business Overview
Table 112. Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 113. Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Product
Table 114. Mirati Therapeutics Recent Developments/Updates
Table 115. Novartis Corporation Information
Table 116. Novartis Description and Business Overview
Table 117. Novartis Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 118. Novartis Histone Deacetylase (HDAC) Inhibitors Product
Table 119. Novartis Recent Developments/Updates
Table 120. Onxeo Corporation Information
Table 121. Onxeo Description and Business Overview
Table 122. Onxeo Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 123. Onxeo Histone Deacetylase (HDAC) Inhibitors Product
Table 124. Onxeo Recent Developments/Updates
Table 125. Repligen Corporation Information
Table 126. Repligen Description and Business Overview
Table 127. Repligen Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 128. Repligen Histone Deacetylase (HDAC) Inhibitors Product
Table 129. Repligen Recent Developments/Updates
Table 130. TetraLogic Corporation Information
Table 131. TetraLogic Description and Business Overview
Table 132. TetraLogic Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 133. TetraLogic Histone Deacetylase (HDAC) Inhibitors Product
Table 134. TetraLogic Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Histone Deacetylase (HDAC) Inhibitors Distributors List
Table 138. Histone Deacetylase (HDAC) Inhibitors Customers List
Table 139. Histone Deacetylase (HDAC) Inhibitors Market Trends
Table 140. Histone Deacetylase (HDAC) Inhibitors Market Drivers
Table 141. Histone Deacetylase (HDAC) Inhibitors Market Challenges
Table 142. Histone Deacetylase (HDAC) Inhibitors Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Histone Deacetylase (HDAC) Inhibitors
Figure 2. Global Histone Deacetylase (HDAC) Inhibitors Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Histone Deacetylase (HDAC) Inhibitors Market Share by Type in 2022 & 2029
Figure 4. Fatty Acid Product Picture
Figure 5. Hydroxamate Product Picture
Figure 6. Cyclic Peptide Product Picture
Figure 7. Benzamide Product Picture
Figure 8. Global Histone Deacetylase (HDAC) Inhibitors Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Histone Deacetylase (HDAC) Inhibitors Market Share by Application in 2022 & 2029
Figure 10. Treatment of Malignant Tumors
Figure 11. Chronic Disease Treatment
Figure 12. Others
Figure 13. Global Histone Deacetylase (HDAC) Inhibitors Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Histone Deacetylase (HDAC) Inhibitors Market Size (2018-2029) & (US$ Million)
Figure 15. Global Histone Deacetylase (HDAC) Inhibitors Sales (2018-2029) & (MT)
Figure 16. Global Histone Deacetylase (HDAC) Inhibitors Average Price (USD/MT) & (2018-2029)
Figure 17. Histone Deacetylase (HDAC) Inhibitors Report Years Considered
Figure 18. Histone Deacetylase (HDAC) Inhibitors Sales Share by Manufacturers in 2022
Figure 19. Global Histone Deacetylase (HDAC) Inhibitors Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Histone Deacetylase (HDAC) Inhibitors Players: Market Share by Revenue in 2022
Figure 21. Histone Deacetylase (HDAC) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Histone Deacetylase (HDAC) Inhibitors Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Country (2018-2029)
Figure 24. North America Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Country (2018-2029)
Figure 25. U.S. Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Country (2018-2029)
Figure 28. Europe Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Country (2018-2029)
Figure 29. Germany Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Region (2018-2029)
Figure 36. China Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Taiwan Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Indonesia Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Thailand Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Malaysia Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Philippines Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Latin America Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Country (2018-2029)
Figure 47. Latin America Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Country (2018-2029)
Figure 48. Mexico Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Brazil Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Argentina Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Country (2018-2029)
Figure 52. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Country (2018-2029)
Figure 53. Turkey Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. U.A.E Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Global Sales Market Share of Histone Deacetylase (HDAC) Inhibitors by Type (2018-2029)
Figure 57. Global Revenue Market Share of Histone Deacetylase (HDAC) Inhibitors by Type (2018-2029)
Figure 58. Global Histone Deacetylase (HDAC) Inhibitors Price (USD/MT) by Type (2018-2029)
Figure 59. Global Sales Market Share of Histone Deacetylase (HDAC) Inhibitors by Application (2018-2029)
Figure 60. Global Revenue Market Share of Histone Deacetylase (HDAC) Inhibitors by Application (2018-2029)
Figure 61. Global Histone Deacetylase (HDAC) Inhibitors Price (USD/MT) by Application (2018-2029)
Figure 62. Histone Deacetylase (HDAC) Inhibitors Value Chain
Figure 63. Histone Deacetylase (HDAC) Inhibitors Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed